EC Number   |
Inhibitors |
Structure |
|---|
    1.3.98.1 | 1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzhydryl-amide 5-benzylamide |
minimum inhibitory concentration above 0.032 mg/ml |
   |
| 1.3.98.1 | 1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzylamide 5-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide] |
minimum inhibitory concentration 0.003 mg/ml |
|
| 1.3.98.1 | 1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-benzylamide 3-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide] |
minimum inhibitory concentration above 0.032 mg/ml |
|
| 1.3.98.1 | 1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-phenylamide 3-[(pyridin-3-ylmethyl)-amide] |
minimum inhibitory concentration 0.0005 mg/ml |
|
| 1.3.98.1 | 1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide] 3-[(tetrahydro-furan-2-yl)-amide] |
minimum inhibitory concentration above 0.032 mg/ml |
|
| 1.3.98.1 | 2,3-dihydrotriazolo[4,5-d]pyrimidine-5,7-dione |
- |
|
| 1.3.98.1 | 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid |
- |
|
| 1.3.98.1 | 2-methyl-3-nitro-N-[3-(trifluoromethyl)phenyl]benzamide |
50% inhibition at 0.00008 mM, wild type, 0.00037 mM, mutant R265A, 0.120, mutant H185A |
|
| 1.3.98.1 | 2-methyl-N-1-naphthyl-3-nitrobenzamide |
50% inhibition at 0.00008 mM, wild type, 0.00048 mM, mutant R265A, 0.180, mutant H185A |
|
| 1.3.98.1 | 2-thioorotate |
orotate analogue, 50% inhibition at 0.018 mM |
|
